Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 18 | 2024 | 1242 | 3.650 |
Why?
|
| Adult Stem Cells | 2 | 2021 | 73 | 1.370 |
Why?
|
| Cell Cycle Proteins | 9 | 2021 | 2045 | 1.340 |
Why?
|
| AMP-Activated Protein Kinases | 5 | 2020 | 413 | 1.320 |
Why?
|
| Leukemia, Myeloid, Acute | 9 | 2022 | 6915 | 1.170 |
Why?
|
| Hematopoiesis | 5 | 2022 | 560 | 1.120 |
Why?
|
| Erythroid Cells | 2 | 2024 | 49 | 1.030 |
Why?
|
| Transcription Factors | 5 | 2021 | 5270 | 0.940 |
Why?
|
| Homeostasis | 4 | 2021 | 950 | 0.910 |
Why?
|
| Dioxygenases | 1 | 2024 | 159 | 0.900 |
Why?
|
| Polycomb Repressive Complex 1 | 4 | 2022 | 89 | 0.880 |
Why?
|
| Leukemia | 6 | 2021 | 1635 | 0.850 |
Why?
|
| Estrogens | 2 | 2018 | 751 | 0.830 |
Why?
|
| Nicotinamide-Nucleotide Adenylyltransferase | 1 | 2021 | 14 | 0.810 |
Why?
|
| Histone Chaperones | 1 | 2021 | 32 | 0.800 |
Why?
|
| Neoplastic Stem Cells | 3 | 2021 | 1443 | 0.770 |
Why?
|
| CRISPR-Cas Systems | 3 | 2018 | 323 | 0.750 |
Why?
|
| Acetyl Coenzyme A | 1 | 2019 | 23 | 0.720 |
Why?
|
| Megakaryocyte-Erythroid Progenitor Cells | 1 | 2019 | 5 | 0.710 |
Why?
|
| Gene Editing | 3 | 2018 | 216 | 0.690 |
Why?
|
| Saccharomyces cerevisiae Proteins | 5 | 2005 | 445 | 0.680 |
Why?
|
| Polycomb-Group Proteins | 1 | 2018 | 42 | 0.640 |
Why?
|
| Saccharomyces cerevisiae | 5 | 2005 | 621 | 0.630 |
Why?
|
| Anemia | 1 | 2024 | 689 | 0.630 |
Why?
|
| Cell Differentiation | 4 | 2024 | 4078 | 0.610 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 115 | 0.610 |
Why?
|
| Adipocytes | 1 | 2019 | 305 | 0.600 |
Why?
|
| Endoribonucleases | 1 | 2018 | 107 | 0.600 |
Why?
|
| Clone Cells | 1 | 2018 | 555 | 0.580 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2022 | 2488 | 0.560 |
Why?
|
| Estrogen Receptor alpha | 2 | 2018 | 701 | 0.540 |
Why?
|
| DNA-Binding Proteins | 6 | 2024 | 4821 | 0.530 |
Why?
|
| Mice | 22 | 2022 | 34495 | 0.500 |
Why?
|
| Mice, Inbred C57BL | 10 | 2021 | 6942 | 0.490 |
Why?
|
| Cell Cycle | 5 | 2012 | 2084 | 0.490 |
Why?
|
| Stem Cells | 4 | 2019 | 1213 | 0.490 |
Why?
|
| Fungal Proteins | 3 | 2004 | 254 | 0.480 |
Why?
|
| Animals | 29 | 2022 | 59536 | 0.460 |
Why?
|
| Carcinogenesis | 3 | 2022 | 1026 | 0.460 |
Why?
|
| DNA Damage | 6 | 2019 | 1954 | 0.450 |
Why?
|
| Azacitidine | 1 | 2019 | 1149 | 0.430 |
Why?
|
| Spleen | 3 | 2024 | 676 | 0.420 |
Why?
|
| Guided Tissue Regeneration | 1 | 2011 | 7 | 0.410 |
Why?
|
| Energy Metabolism | 3 | 2020 | 992 | 0.390 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2019 | 2359 | 0.390 |
Why?
|
| Protein Kinases | 1 | 2014 | 874 | 0.350 |
Why?
|
| Stem Cell Niche | 2 | 2020 | 94 | 0.350 |
Why?
|
| Oxidative Stress | 1 | 2015 | 1129 | 0.340 |
Why?
|
| Histones | 3 | 2021 | 1466 | 0.330 |
Why?
|
| Clonal Evolution | 2 | 2020 | 253 | 0.320 |
Why?
|
| Bone Marrow | 1 | 2015 | 2358 | 0.310 |
Why?
|
| Phleomycins | 2 | 2004 | 7 | 0.300 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2022 | 476 | 0.290 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2020 | 1265 | 0.290 |
Why?
|
| DNA, Fungal | 2 | 2004 | 127 | 0.280 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2019 | 560 | 0.280 |
Why?
|
| Mice, Transgenic | 5 | 2021 | 4143 | 0.280 |
Why?
|
| Cell Self Renewal | 2 | 2021 | 62 | 0.250 |
Why?
|
| Exodeoxyribonucleases | 1 | 2004 | 104 | 0.250 |
Why?
|
| Endodeoxyribonucleases | 1 | 2004 | 105 | 0.250 |
Why?
|
| Phosphoproteins | 3 | 2012 | 1152 | 0.240 |
Why?
|
| Iron | 2 | 2024 | 376 | 0.220 |
Why?
|
| Selenium | 1 | 2022 | 47 | 0.210 |
Why?
|
| Mice, Knockout | 4 | 2021 | 5710 | 0.210 |
Why?
|
| Proteostasis | 1 | 2022 | 52 | 0.210 |
Why?
|
| Gene Ontology | 1 | 2021 | 80 | 0.200 |
Why?
|
| NAD | 1 | 2021 | 89 | 0.200 |
Why?
|
| Signal Transduction | 9 | 2020 | 11965 | 0.190 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2020 | 35 | 0.190 |
Why?
|
| Checkpoint Kinase 2 | 4 | 2004 | 126 | 0.190 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2020 | 65 | 0.190 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2012 | 1546 | 0.180 |
Why?
|
| Ribonucleoproteins | 2 | 2018 | 123 | 0.180 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2020 | 54 | 0.180 |
Why?
|
| PAX3 Transcription Factor | 1 | 2019 | 37 | 0.180 |
Why?
|
| Gene Deletion | 4 | 2016 | 1442 | 0.180 |
Why?
|
| Lipid Peroxidation | 1 | 2020 | 157 | 0.170 |
Why?
|
| Multiprotein Complexes | 2 | 2012 | 395 | 0.170 |
Why?
|
| Endoplasmic Reticulum | 1 | 2020 | 308 | 0.170 |
Why?
|
| Reperfusion Injury | 1 | 2020 | 145 | 0.170 |
Why?
|
| Animals, Newborn | 2 | 2021 | 1338 | 0.170 |
Why?
|
| Preleukemia | 1 | 2018 | 15 | 0.160 |
Why?
|
| Phosphorylation | 7 | 2020 | 4804 | 0.160 |
Why?
|
| Acetylation | 1 | 2019 | 508 | 0.160 |
Why?
|
| Adipogenesis | 1 | 2019 | 105 | 0.160 |
Why?
|
| Hematologic Diseases | 1 | 2019 | 242 | 0.160 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2018 | 93 | 0.160 |
Why?
|
| Cell Division | 2 | 2014 | 2489 | 0.160 |
Why?
|
| INDEL Mutation | 1 | 2018 | 112 | 0.160 |
Why?
|
| Methylation | 1 | 2019 | 597 | 0.150 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 7222 | 0.150 |
Why?
|
| Mice, Inbred NOD | 2 | 2020 | 905 | 0.150 |
Why?
|
| Humans | 21 | 2024 | 261506 | 0.150 |
Why?
|
| Environmental Exposure | 1 | 2019 | 288 | 0.150 |
Why?
|
| Cellular Senescence | 1 | 2019 | 382 | 0.150 |
Why?
|
| Blood Platelets | 1 | 2022 | 731 | 0.150 |
Why?
|
| Mutation | 7 | 2020 | 15179 | 0.150 |
Why?
|
| Genes, Neoplasm | 1 | 2018 | 324 | 0.140 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2012 | 986 | 0.140 |
Why?
|
| Cellular Microenvironment | 1 | 2016 | 41 | 0.140 |
Why?
|
| Models, Biological | 2 | 2021 | 3254 | 0.140 |
Why?
|
| Replication Protein A | 2 | 2005 | 35 | 0.130 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 854 | 0.130 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 1742 | 0.130 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 677 | 0.130 |
Why?
|
| RNA Interference | 1 | 2019 | 1408 | 0.130 |
Why?
|
| Prosencephalon | 1 | 2014 | 43 | 0.120 |
Why?
|
| Cell Proliferation | 4 | 2016 | 7226 | 0.120 |
Why?
|
| Erythropoiesis | 1 | 2014 | 74 | 0.120 |
Why?
|
| Translocation, Genetic | 1 | 2019 | 1245 | 0.120 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 222 | 0.110 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 2216 | 0.110 |
Why?
|
| Protein Binding | 1 | 2019 | 3438 | 0.110 |
Why?
|
| Cell Count | 1 | 2014 | 508 | 0.110 |
Why?
|
| Bone Marrow Transplantation | 1 | 2018 | 1581 | 0.110 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2019 | 923 | 0.110 |
Why?
|
| Trans-Activators | 1 | 2019 | 1555 | 0.110 |
Why?
|
| Neural Stem Cells | 1 | 2014 | 181 | 0.110 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2013 | 161 | 0.110 |
Why?
|
| Cytosol | 1 | 2012 | 238 | 0.100 |
Why?
|
| Age Factors | 1 | 2021 | 5377 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2018 | 5637 | 0.100 |
Why?
|
| Sex Characteristics | 1 | 2014 | 417 | 0.100 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3821 | 0.100 |
Why?
|
| Cell Survival | 2 | 2010 | 3045 | 0.100 |
Why?
|
| Kidney | 1 | 2020 | 2146 | 0.100 |
Why?
|
| Spindle Apparatus | 1 | 2010 | 93 | 0.090 |
Why?
|
| Centrosome | 1 | 2010 | 95 | 0.090 |
Why?
|
| Enzyme Activation | 2 | 2012 | 1764 | 0.090 |
Why?
|
| Pancytopenia | 1 | 2010 | 120 | 0.090 |
Why?
|
| Ovary | 1 | 2014 | 668 | 0.090 |
Why?
|
| Sulfonamides | 1 | 2019 | 1823 | 0.090 |
Why?
|
| Catalytic Domain | 1 | 2010 | 303 | 0.090 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2010 | 265 | 0.090 |
Why?
|
| Aneuploidy | 1 | 2010 | 369 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 5159 | 0.080 |
Why?
|
| Aging | 2 | 2014 | 1582 | 0.080 |
Why?
|
| Cell Death | 1 | 2010 | 671 | 0.080 |
Why?
|
| Nerve Net | 1 | 2011 | 257 | 0.080 |
Why?
|
| Male | 6 | 2020 | 123000 | 0.080 |
Why?
|
| Female | 7 | 2022 | 141928 | 0.080 |
Why?
|
| Regeneration | 1 | 2010 | 279 | 0.080 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 14551 | 0.080 |
Why?
|
| Apoptosis | 1 | 2021 | 7591 | 0.070 |
Why?
|
| Disease Progression | 1 | 2018 | 6682 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2010 | 1064 | 0.070 |
Why?
|
| Integrases | 2 | 2021 | 262 | 0.070 |
Why?
|
| Sirolimus | 1 | 2010 | 814 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 7551 | 0.070 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 189 | 0.070 |
Why?
|
| Genes, Fungal | 1 | 2004 | 84 | 0.060 |
Why?
|
| Genes, cdc | 1 | 2004 | 81 | 0.060 |
Why?
|
| Mitochondria | 1 | 2010 | 1282 | 0.060 |
Why?
|
| Methyl Methanesulfonate | 1 | 2003 | 3 | 0.060 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2003 | 43 | 0.060 |
Why?
|
| G2 Phase | 1 | 2003 | 206 | 0.050 |
Why?
|
| Protein Aggregates | 1 | 2022 | 27 | 0.050 |
Why?
|
| RNA, Ribosomal | 1 | 2022 | 83 | 0.050 |
Why?
|
| Proteins | 1 | 2010 | 1963 | 0.050 |
Why?
|
| S Phase | 1 | 2003 | 281 | 0.050 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2003 | 430 | 0.050 |
Why?
|
| Receptor, TIE-2 | 1 | 2021 | 82 | 0.050 |
Why?
|
| Pregnancy | 1 | 2014 | 7573 | 0.050 |
Why?
|
| Mitosis | 1 | 2003 | 615 | 0.050 |
Why?
|
| DNA Replication | 1 | 2004 | 744 | 0.050 |
Why?
|
| Cyclohexylamines | 1 | 2020 | 16 | 0.050 |
Why?
|
| Sequence Deletion | 1 | 2003 | 875 | 0.050 |
Why?
|
| Phenylenediamines | 1 | 2020 | 23 | 0.050 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2021 | 159 | 0.050 |
Why?
|
| A549 Cells | 1 | 2020 | 124 | 0.040 |
Why?
|
| Protein Phosphatase 2C | 1 | 2019 | 75 | 0.040 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2020 | 94 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2021 | 429 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2022 | 467 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 208 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2005 | 1439 | 0.040 |
Why?
|
| Oncogenes | 1 | 2022 | 673 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2020 | 550 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2013 | 1489 | 0.040 |
Why?
|
| Heterografts | 1 | 2020 | 733 | 0.040 |
Why?
|
| Kinetics | 1 | 2021 | 2049 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2015 | 5061 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 470 | 0.040 |
Why?
|
| Aged | 2 | 2020 | 70117 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2020 | 741 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 15862 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2020 | 492 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2020 | 1113 | 0.030 |
Why?
|
| Leukocyte Common Antigens | 1 | 2016 | 188 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2013 | 1678 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 1084 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 276 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2003 | 1823 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2013 | 2054 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 4053 | 0.030 |
Why?
|
| Antimitotic Agents | 1 | 2014 | 8 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 8873 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 634 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2014 | 151 | 0.030 |
Why?
|
| Glucose | 1 | 2020 | 1248 | 0.030 |
Why?
|
| DNA Repair | 2 | 2016 | 1872 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2020 | 1682 | 0.030 |
Why?
|
| Rapamycin-Insensitive Companion of mTOR Protein | 1 | 2012 | 27 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 2483 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2012 | 68 | 0.030 |
Why?
|
| Neuroglia | 1 | 2014 | 223 | 0.030 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 85 | 0.030 |
Why?
|
| Blood Cells | 1 | 2012 | 127 | 0.030 |
Why?
|
| Cell Separation | 1 | 2014 | 612 | 0.030 |
Why?
|
| Protein Subunits | 1 | 2013 | 274 | 0.030 |
Why?
|
| Dacarbazine | 1 | 2014 | 485 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2012 | 260 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2014 | 238 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2015 | 750 | 0.030 |
Why?
|
| Pancreas | 1 | 2015 | 718 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 2291 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2020 | 1471 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2012 | 266 | 0.020 |
Why?
|
| Piperazines | 1 | 2020 | 2101 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 987 | 0.020 |
Why?
|
| Genomics | 1 | 2020 | 2738 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 5047 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 1487 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2015 | 1331 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 9244 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2020 | 3518 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2012 | 984 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 2074 | 0.020 |
Why?
|
| Cell Line | 1 | 2013 | 5114 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 3033 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2012 | 2022 | 0.010 |
Why?
|
| DNA, Single-Stranded | 1 | 2004 | 106 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 392 | 0.010 |
Why?
|
| Phenotype | 1 | 2014 | 6295 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 600 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2004 | 613 | 0.010 |
Why?
|
| DNA Primers | 1 | 2002 | 1399 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 3552 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2002 | 1258 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 12926 | 0.010 |
Why?
|
| Base Sequence | 1 | 2002 | 4917 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2012 | 6550 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 86204 | 0.010 |
Why?
|
| Neoplasms | 1 | 2009 | 15193 | 0.000 |
Why?
|